<DOC>
	<DOCNO>NCT00242749</DOCNO>
	<brief_summary>· To evaluate disease free survival rate 2 year patient advance head neck carcinoma treat ZD1839 250 mg administer daily combination cisplatin standard course radiotherapy .</brief_summary>
	<brief_title>IRESSA Combination With Cisplatin &amp; Radiotherapy Patients With Advanced Head &amp; Neck Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Histologically confirm squamous head neck carcinoma 2 . Extralaryngeal tumour laryngeal tumour inoperable ( resectable ) consider Head Neck Cancer Committee 3 . Stage IIIIV ( IVa IVb ) disease 4 . Measurable disease accord RECIST criterion 5 . Aged 18 year old 6 . Eastern Cooperative Oncology Group ( ECOG ) performance status ( PS ) 01 7 . Normal renal , haematological ( neutrophils &gt; 1´5 x 109/ L platelet &gt; 100 x 109/L ) liver function 1 . Previous treatment initial disease ( neck dissection N3 allow ) 2 . Other coexist malignancy malignancy diagnose within last 5 year exception basal cell carcinoma cervical cancer situ 3 . Incomplete heal previous oncologic surgery 4 . Absolute neutrophil count ( ANC ) less 1.5 x 109/ L , platelets less 100x 109/L 5 . Serum bilirubin great 1.25 time upper limit reference range ( ULRR ) 6 . In opinion investigator , evidence severe uncontrolled systemic disease ( e.g . unstable uncompensated respiratory , cardiac , hepatic renal disease ) 7 . Serum creatinine great 1.25 time ULRR 8 . ALT AST great 2.5 time ULRR 9 . Evidence significant clinical disorder laboratory find make undesirable patient participate trial 10 . Active dermatosis ( e.g . psoriasis , eczema ) 11 . Corneal abnormality ( scar , congenital abnormality corneal tear film ) , history dry eye syndrome ocular surface diseases neurological disorder 12 . Concomitant use phenytoin , carbamazepine , barbiturate , rifampicin drug know corneal toxicity 13 . Pregnancy breastfeeding ( woman childbearing potential ) 14 . Patient incapacity reliably follow treatment follow family , economic geographical reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Head Neck Cancer Disease</keyword>
	<keyword>Head Cancer</keyword>
	<keyword>Neck Cancer</keyword>
	<keyword>Cancer Head</keyword>
	<keyword>Cancer Neck</keyword>
	<keyword>Cancer Head</keyword>
	<keyword>Cancer Head Neck</keyword>
	<keyword>Cancer Neck</keyword>
	<keyword>Neoplasms , Head Neck</keyword>
</DOC>